Integrative genomic analyses in adipocytes implicate DNA methylation in human obesity and diabetes.
Integrative genomic analyses in adipocytes implicate DNA methylation in human obesity and diabetes.
复制标题
DOI:
10.1038/s41467-023-38439-z
复制
发表时间:
2023-05-15
影响因子:
16.6
通讯作者:
Scott, William R.
中科院分区:
文献类型:
--
作者:
McAllan, Liam;Baranasic, Damir;Villicana, Sergio;Brown, Scarlett;Zhang, Weihua;Lehne, Benjamin;Adamo, Marco;Jenkinson, Andrew;Elkalaawy, Mohamed;Mohammadi, Borzoueh;Hashemi, Majid;Fernandes, Nadia;Lambie, Nathalie;Williams, Richard;Christiansen, Colette;Yang, Youwen;Zudina, Liudmila;Lagou, Vasiliki;Tan, Sili;Castillo-Fernandez, Juan;King, James W. D.;Soong, Richie;Elliott, Paul;Scott, James;Prokopenko, Inga;Cebola, Ines;Loh, Marie;Lenhard, Boris;Batterham, Rachel L.;Bell, Jordana T.;Chambers, John C.;Kooner, Jaspal S.;Scott, William R.
DNA methylation variations are prevalent in human obesity but evidence of a causative role in disease pathogenesis is limited. Here, we combine epigenome-wide association and integrative genomics to investigate the impact of adipocyte DNA methylation variations in human obesity. We discover extensive DNA methylation changes that are robustly associated with obesity (N = 190 samples, 691 loci in subcutaneous and 173 loci in visceral adipocytes, P < 1 × 10-7). We connect obesity-associated methylation variations to transcriptomic changes at >500 target genes, and identify putative methylation-transcription factor interactions. Through Mendelian Randomisation, we infer causal effects of methylation on obesity and obesity-induced metabolic disturbances at 59 independent loci. Targeted methylation sequencing, CRISPR-activation and gene silencing in adipocytes, further identifies regional methylation variations, underlying regulatory elements and novel cellular metabolic effects. Our results indicate DNA methylation is an important determinant of human obesity and its metabolic complications, and reveal mechanisms through which altered methylation may impact adipocyte functions. DNA methylation variation is associated with human obesity but a whether it plays a causal role in disease pathogenesis is unclear. Here, the authors perfom an integrative genomic study in human adipocytes to show that DNA methylation variations contribute to obesity and type 2 diabetes susceptibility, revealing underlying genomic and molecular mechanisms.
登录
查看更多内容
影响因子:
12.4
作者:
Chen Q;Shou P;Zheng C;Jiang M;Cao G;Yang Q;Cao J;Xie N;Velletri T;Zhang X;Xu C;Zhang L;Yang H;Hou J;Wang Y;Shi Y
通讯作者:
Shi Y
影响因子:
16.6
作者:
Bacos K;Gillberg L;Volkov P;Olsson AH;Hansen T;Pedersen O;Gjesing AP;Eiberg H;Tuomi T;Almgren P;Groop L;Eliasson L;Vaag A;Dayeh T;Ling C
通讯作者:
Ling C
影响因子:
3.5
作者:
Antonio Perez-Mancera, Pedro;Bermejo-Rodriguez, Camino;Sanchez-Garcia, Isidro
通讯作者:
Sanchez-Garcia, Isidro
影响因子:
20.8
作者:
Chen Z;Miao F;Braffett BH;Lachin JM;Zhang L;Wu X;Roshandel D;Carless M;Li XA;Tompkins JD;Kaddis JS;Riggs AD;Paterson AD;DCCT/EDIC Study Group;Natarajan R
通讯作者:
Natarajan R
DOI:
10.1007/978-1-61779-367-7_14
发表时间:
2012
期刊:
Methods in molecular biology (Clifton, N.J.)
影响因子:
--
作者:
Carswell, Kirstin A;Lee, Mi-Jeong;Fried, Susan K
通讯作者:
Fried, Susan K